Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : RMGG -- Ignore unavailable to you. Want to Upgrade?

To: Coop who wrote (71)	5/31/1998 11:51:00 AM
From: Vicki G	Respond to of 1170

Coop, what you've said is the way I understand it so far. Did you see the other Global news releases: stockfind.lycos.com I've found that the Lycos news search brings back more than Yahoo. (I searched on 'biofarm'). stockfind.lycos.com One other note: if I recall correctly, on that CNBC (audio) interview, Bell was asked if RMGG would need to borrow money for expansion, and Bell said that Litchfield/Global? would finance RMGG for a year. I have a paper copy of the RMGG news release from April 8, 1998, that was on their web site before the current one (May 7). It talks about the financing. I'll key it in next post. Vicki

To: Coop who wrote (71)	5/31/1998 1:02:00 PM
From: Vicki G	Read Replies (2) \| Respond to of 1170

Here is the news release that was on RMGG's web site before the current one of May 7 (keyed in from paper copy). Maybe Annette can give us other past news releases? News Release Page FINANCING AGREEMENT ANNOUNCED 8 April 1998 Rocky Mountain Ginseng, Inc. (OTCBB:RMGG) has entered into an agreement with Litchfield Continental, Ltd. Litchfield will provide $650,000 to RMGG to complete the purchase of Fuzhou Fujiang Drugs Co., Ltd. in China (see our news release dated February 23, 1998). Litchfield will also provide additional funds to support RMGG's expansion plans. The agreement between RMGG and Litchfield will allow Litchfield to acquire a controlling interest in RMGG. Litchfield entered into an agreement with Global Spill Management, Inc. (OTCBB:GEGI) whereby Global Spill is acquiring Litchfield's subsidiary, Biofarm S.A, a Romanian-based pharmaceutical company (see Global Spill's news release dated April 7, 1998). Fuzhou Fujiang Drugs Co., Ltd. possesses the necessary permits and licenses for both RMGG and Biofarm S.A to produce and distribute their respective products in China. Fuzhou Fujiang Drugs Co., Ltd. has established its own sales and distribution network of 131 outlets in key Chinese business centers including Fujian province, Jiansu province, Hubei province, Zhegian province, Hunan province, Beijing City, Shanxi province, Shishan province, Chongqing City, Guandong province, Xnhui province, Shanghai City and Shandong province. RMGG is preparing to purchase processing equipment for the production of its exclusive value added ginseng products in the Fuzhou factory. For further information and updates please phone, fax or e-mail your name and preferred method of receipt of future news releases to Robert L Bell at: phone (604)420-0095, fax (604)420-0096 or e-mail rlbell@direct.ca. The statements made in this news release may contain forward looking statements. Actual events or results may differ from tha Company's expectations. Certain risk factors may also affect the results achieved by the Company. (end news release) More notes: According to Global's March 18 news release, "Litchfield, a British Virgin Islands entity located in London, is a diversified holding company with holdings in chemical, real property, maritime, mining, research and development and financial management companies." It mentions in the same news release that Global intends to become listed on the NASDAQ NMS. (What is 'NMS'?) stockfind.lycos.com